Answers are grounded in this paper and cite their sources.
Introduction Dystonia is characterized by dysfunctional movements and postures and current treatments aim to reduce unwanted muscle activity. Dystonia also encompasses non-motor symptoms which are becoming increasingly recognized as important contributors to quality of life. Less attention has been paid to treating these non-motor symptoms. This systematic review was undertaken to describe what is known regarding non-motor symptom treatment in dystonia. Methods A systematic review was undertaken of the published literature from 2019 to 2025. Studies on dystonia that included description of non-motor symptoms and changes after treatment were included. Results 408 records were identified for review with 89 meeting inclusion and exclusion criteria for full review. 22 reports and 10 additional studies from review of references were included in the review. Treatments were stratified by type of treatment (e.g., surgical, non-invasive neurostimulation, and botulinum toxin injection) as well as by type of dystonia (e.g., generalized vs. focal vs. segmental). Response of non-motor symptoms to surgical treatment were mixed. Ablative therapy showed some improvements in non-motor symptoms but with the inherent risks of ablative procedures. Botulinum toxin consistently improved mood and pain across multiple dystonia populations. Conclusion This review summarizes the current state of treatment effects of non-motor symptoms in dystonia. In most cases, the treatments were primarily aimed at motor symptoms but changes were sometimes seen in non-motor symptoms as well. Better detection and treatment of non-motor symptoms in dystonia are needed to wholly treat patients with dystonia.
No takes yet. Share an insight, caveat, or question.
Sugar et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: